Abstract
Background The Productivity Adjusted Life Year (PALY) metric is a novel measure for exploring the societal impact of health conditions on work productivity. Given that stroke is a major cause of DALYs (disability-adjusted life years) and the crucial role of caregivers in post-stroke care our study aims to quantify the PALY loss associated with stroke caregivers and the impact on their quality of life (QoL) by calculating quality-adjusted life years (QALYs).
Method Dynamic life table modeling was used to simulate the follow-up of the Australian working-age population (aged 15–65 years) over 30 years of follow-up (2023-2052 inclusive). The model compared the Australian stroke informal carer group and a hypothetical cohort of non-carers. Key data was obtained from literature and publicly available data. The model was constructed using Microsoft Excel® (Microsoft Corporation, Redmond, WA, US). Labor force participation rates were applied to population estimates to arrive at the approximate number of full-time equivalent (FTE) which was then multiplied by the productivity index and years of life lived (YLL) to estimate PALYs and the utility values were multiplied by YLL to estimate QALYs.
Results Over a 30-year period, an estimated 35,337 QALYs and 87,773 PALYs and AU$ 19.1 billion were lost due to the health and productivity burden attributed to the provision of informal care for stroke patients. On average, annual informal carer losses were 1,178 QALYs and 2,926 PALYS, corresponding to AU$ 636 million per year in productivity loss.
Conclusion Our analyses demonstrate the health and economic consequences of providing care to stroke patients over the forthcoming decades and highlight the need for interventions to reduce the burden of stroke and its impact on caregivers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was conducted as a part of PhD program for which Deakin University provided scholarship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in the analysis is included in the supplement.
